EVMN
Evommune, Inc.
NYSE · Healthcare · Biotechnology · US
$5.27
+1.93%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-54.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 15, 2026 | Pena Luis C. · director, officer: President & CEO | A-Award | 1,115 | $7.02 |
Institutional positioning
13F filings over the trailing two quarters
New 81Increased 64Reduced 26Sold out 16
| Filer | Action | Shares | Filed |
|---|---|---|---|
| EQT Fund Management S.a r.l. | Increased | 5,288,313 | Aug 13, 2026 |
| EQT FUND MANAGEMENT S.A R.L. | Unchanged | 4,929,633 | May 14, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 3,494,638 | Aug 14, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Increased | 3,494,638 | May 15, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 1,940,939 | Aug 14, 2026 |
| Pivotal bioVenture Partners Investment Advisor LLC | Unchanged | 1,926,943 | Aug 13, 2026 |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | Unchanged | 1,926,943 | May 14, 2026 |
| ANDERA PARTNERS | Unchanged | 1,897,362 | May 11, 2026 |
| JPMORGAN CHASE & CO | Increased | 1,553,132 | Aug 12, 2026 |
| RTW INVESTMENTS, LP | Increased | 1,502,235 | May 15, 2026 |
| RTW INVESTMENTS, LP | Unchanged | 1,502,235 | Aug 14, 2026 |
| JPMORGAN CHASE & CO | Increased | 1,459,420 | May 13, 2026 |
| BIOIMPACT CAPITAL LLC | Increased | 1,455,863 | May 15, 2026 |
| Nan Fung Group Holdings Ltd | Unchanged | 1,441,032 | Aug 13, 2026 |
| NAN FUNG GROUP HOLDINGS LTD | Unchanged | 1,441,032 | May 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 15, 2026